Newstral
Article
NZ Herald on 2022-08-02 08:31
A2 Milk cools speculation of imminent FDA approval
Related news
- Investor love for infant formula maker a2 Milk cools offSydney Morning Herald
- US FDA defers infant formula request: What it means for a2 MilkNZ Herald
- A2 milk label war settlesfarmonline.com.au
- Shares in a2 Milk continue bubbling higherSydney Morning Herald
- NZ class action launched against a2 MilkNZ Herald
- A2 Milk faces 3rd class action claim over disclosureNZ Herald
- A2 Milk share price rallies on takeover talkNZ Herald
- NA2 Milk raises $40mnorthqueenslandregister.com.au
- RBA cools March rate cut speculationSydney Morning Herald
- A2 Milk appoints China exec to boost market shareSydney Morning Herald
- ASX set to slip; a2 Milk profit down 80%Sydney Morning Herald
- Continuous Disclosure: Will a2 Milk ever pay a dividend?NZ Herald
- a2 Milk post record profitSydney Morning Herald
- FA2 Milk revises up forecastsfarmweekly.com.au
- Market close: NZ shares rise on back of soaring a2 MilkNZ Herald
- A2 Milk sees green shoots of recovery after first-half profit slumpNZ Herald